In 1999, Terumo Corporation merged three of the most established and trusted brands in perfusion products — CAPIOX®, Sarns™ and CDI® — to create Terumo Cardiovascular Systems. The company inherited a rich history that stretches back to the pioneering years of open-heart surgery.
Since 1999, Terumo Cardiovascular has expanded its cardiac surgery product line to include vascular grafts, endoscopic vessel harvesting, and more.
Terumo Corporation, Terumo Cardiovascular’s parent company, spans an even greater time period in medical device development. Its first product, a clinical thermometer, was developed in the early 1920s. It has continued to grow and is now one of the largest medical device manufacturers in the world. Visit Terumo Corporation’s website to view their full history.
Today, in virtually every cardiac surgery center around the world, heart teams choose products made by Terumo Cardiovascular.
The Sekisen Ken-onki is founded, eventually becoming Terumo Corporation
Terumo Corporation introduced its first product — a clinical thermometer
Dick Sarns delivers his first custom-made heart-lung machine
Sarns, Inc. produced the S2000, its first modular heart-lung machine
Terumo America Inc. and Terumo Europe S.A. were founded
CAPIOX® II Oxygenator, the world’s first hollow fiber oxygenator, introduced
Cardiovascular Devices Inc. (CDI) introduced the Gas Stat System, the industry’s first continuous monitor
CAPIOX® E Oxygenator launched, offering venous gravity drainage and an arterial reservoir for ease-of-use
Sarns, Inc. introduced the Sarns™ Modular Perfusion System 8000
CAPIOX® SX Oxygenator launched
CDI® Blood Parameter Monitoring System 500 introduced
Terumo Corporation acquired the Sarns™ and CDI® brands from 3M and merged the technologies with CAPIOX® to form Terumo Cardiovascular Systems
Xcoating™, a non-heparin biocompatible coating, launched
CAPIOX RX Oxygenator introduced
Terumo Cardiovascular Systems entered into an exclusive distribution agreement with Pall Corporation for cardiovascular filters
CAPIOX Baby RX™ (RX05) Neonatal Oxygenator launched
Terumo Corporation acquired Vascutek Ltd., a global leader in artificial vascular grafts
Terumo® Advanced Perfusion System 1 introduced
Terumo Corporation became number one in the global perfusion products market and began to expand its portfolio to new product categories in the cardiac operating room
VirtuoSaph™ Endoscopic Vein Harvesting System launched
Terumo Cardiovascular Systems entered into an exclusive distribution agreement with Harvest Technologies Corporation to distribute SmartPrep® platelet gel therapy in the North American cardiovascular market
TLink™ Data Management System introduced
CAPIOX® RX15/25 Oxygenators launched in the United States, extending its offering of hollow-fiber oxygenators for use with all patients
Terumo Cardiovascular Systems became the exclusive distributor of Vascutek® Vascular Grafts in the United States
CAPIOX® FX Oxygenator, the industry’s first oxygenator with an integrated arterial filter, introduced
CAPIOX® FX05 Oxygenator, the industry’s first pediatric oxygenator with an integrated arterial filter, launched
Terumo Corporation acquired Harvest Technologies Corporation, a leader in the development of point-of-care cell therapy
Terumo Cardiovascular Group acquired the Orpheus™ Perfusion Simulation technology from Ulco Technologies
Terumo Cardiovascular Group formed, creating a global headquarters focused on the needs of cardiac surgery teams worldwide. Terumo Cardiovascular Group acquired the beating heart and stabilization technologies from Estech Cardiothoracic Stabilization Technologies
Terumo Cardiovascular Group became the exclusive distributor of Nonin Medical’s SenSmart™ Model X-100 in the United States
2016 CAPIOX® FX Advance Oxygenator introduced, further reducing prime volume and lowering hemodilution. 2018
510(k) clearance received for the CDI® Blood Parameter Monitoring System 550, adding new parameter for oxygen delivery.
Capiox® NX19 Oxygenator with UltraPrime™ Technology introduced, Terumo’s smallest full-size adult oxygenator to date.
Terumo Cardiovascular Group and Talis Clinical announced partnership to deliver intelligent, real-time guidances to CVOR and CVICU to improve outcomes.
2019 Terumo Cardiovascular Group and Hemostasis introduce BoneSeal® Bone Hemostat. 2020 Terumo Cardiovascular Group updates name to Terumo Cardiovascular and introduces new logo, to focus on its market and customers.